Search - tctmd.com

Displaying 61 - 80 of 108

Sort: Relevancy | Date

Presentation TCT 2018

Overview of Current and Future IVC Filter Devices

Presenter: Jay S. Giri, Akhilesh K. Sista, Rahul S. Patel

September 24, 2018

Presentation TCT 2018

Who Should Get an IVC Filter? Review of the Guidelines

Presenter: Jay S. Giri, Akhilesh K. Sista

September 24, 2018

Presentation TCT 2018

Case #5: Severe Dyspnea in a Patient With HCM and Mid-Cavitary Obstruction

Presenter: Sherif F. Nagueh, Hubert Seggewiss, John S. Douglas Jr, Valerian Fernandes, Vijay Iyer, Srihari S. Naidu, Nish Patel, Alexandre C. Zago

September 24, 2018

Presentation TCT 2018

Cerebral Embolic Protection: Regulatory Perspectives

Presenter: Jeffrey J. Popma, Changfu Wu, Kenneth J. Cavanaugh Jr

September 23, 2018

Presentation TCT 2018

Patient Perspectives on Sham-Controlled Trials

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Debbe McCall

September 23, 2018

Presentation TCT 2018

FDA Perspectives on Sham-Controlled Trials

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Hiren Mistry

September 23, 2018

Presentation TCT 2018

Sham Controls in Renal Denervation Studies: Need to Have vs Nice to Have?

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, David E. Kandzari

September 23, 2018

Presentation TCT 2018

ORBITA One Year Later: What Would I Do Differently, If Anything?

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Rasha Al-Lamee

September 23, 2018

Presentation TCT 2018

Evolution of Caval Valves (CAVI) Last Resort TR Patients Technology and Clinical Updates

Presenter: Alexander Lauten

September 23, 2018

Presentation TCT 2018

Assessing the Severity of TR: Challenges, Inconsistencies, and Grading Schemes

Presenter: Samir R. Kapadia, Ralph Stephan von Bardeleben, João L Cavalcante

September 23, 2018

Presentation TCT 2018

The Rapid Emergence of Trans-Caval TAVR: Techniques and Clinical Outcomes

Presenter: Adam B. Greenbaum

September 22, 2018

Presentation TCT 2018

Point to Consider in the Review of the RDN Related Devices: US Regulatory

Presenter: Kenneth J. Cavanaugh Jr, Takafumi Ueno, Hiren Mistry

September 22, 2018

Presentation TCT 2018

Japanese Perspective and Experience on RDN Studies

Presenter: Kenneth J. Cavanaugh Jr, Takafumi Ueno

September 22, 2018

Presentation TCT 2018

The Overview of Current Evidence of RDN: The Result of RADIANCE-HTN SOLO Trial and SPYRAL HTN-on MED Trial

Presenter: Kenneth J. Cavanaugh Jr, Takafumi Ueno, Justin E. Davies

September 22, 2018

Presentation TCT 2018

TCT-73: Treatment of Severe TRIcuspid Regurgitation in Patients with Advanced Heart Failure with CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL): a controlled prospective randomized trial

Presenter: Rebecca T. Hahn, Jose Luis Navia, Maurizio Taramasso, Henryk Dreger

September 21, 2018

Presentation TCT 2018

First-In-Man Testing of a Dedicated Closure Device for Trans-Caval Access for Transcatheter Aortic Valve Replacement (Transmural Systems)

Presenter: Toby Rogers

September 21, 2018

Presentation TCT 2018

Occlusion of the Superior Vena Cava to Reduce Cardiac Filling Pressures is Safe and Feasible in Acutely Decompensated Heart Failure: A First-in-Man Proof of Concept Study

Presenter: Ulrich P. Jorde, John M. Lasala, Navin K. Kapur

September 21, 2018

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

Presentation TCT 2017

Transcatheter TR Solution 2: Caval Valve Implantation

Presenter: Francesco Maisano, Jason H. Rogers, Hans R. Figulla

November 01, 2017

News Conference News TCT 2017

Shortened DAPT Durations Appear Safe for Patients With ACS Implanted With DES

Todd Neale

November 01, 2017

Advertisement

Overview of Current and Future IVC Filter Devices

Who Should Get an IVC Filter? Review of the Guidelines

Case #5: Severe Dyspnea in a Patient With HCM and Mid-Cavitary Obstruction

Cerebral Embolic Protection: Regulatory Perspectives

Patient Perspectives on Sham-Controlled Trials

FDA Perspectives on Sham-Controlled Trials

Sham Controls in Renal Denervation Studies: Need to Have vs Nice to Have?

ORBITA One Year Later: What Would I Do Differently, If Anything?

Evolution of Caval Valves (CAVI) Last Resort TR Patients Technology and Clinical Updates

Assessing the Severity of TR: Challenges, Inconsistencies, and Grading Schemes

The Rapid Emergence of Trans-Caval TAVR: Techniques and Clinical Outcomes

Point to Consider in the Review of the RDN Related Devices: US Regulatory

Japanese Perspective and Experience on RDN Studies

The Overview of Current Evidence of RDN: The Result of RADIANCE-HTN SOLO Trial and SPYRAL HTN-on MED Trial

TCT-73: Treatment of Severe TRIcuspid Regurgitation in Patients with Advanced Heart Failure with CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL): a controlled prospective randomized trial

First-In-Man Testing of a Dedicated Closure Device for Trans-Caval Access for Transcatheter Aortic Valve Replacement (Transmural Systems)

Occlusion of the Superior Vena Cava to Reduce Cardiac Filling Pressures is Safe and Feasible in Acutely Decompensated Heart Failure: A First-in-Man Proof of Concept Study

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Transcatheter TR Solution 2: Caval Valve Implantation

Shortened DAPT Durations Appear Safe for Patients With ACS Implanted With DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content